Markus is a German executive and entrepreneur with over thirty years of international industry and market experience. Markus has lived and worked extensively in Europe, the USA, Brazil and Asia, and is now focused on the Chilean & Latin American market. He is the Founder of The Ganesha Lab, a Global Biotech Scale-UP providing internationalization, Scale-up and funding services to Biotechnology startups from Latin America. Markus, together with his extraordinary team, board of internationally recognized experts and relevant industry partnerships, has developed methodologies, processes and networks to provide world class services to its clients and results to investors. During his 25 year long career in the Life Science Technology industry with leading manufacturers like Thermo Fisher Scientific and Fisons Instruments, Markus held various leadership positions. He gained significant experience in strategic transitions through market differentiated product innovations resulting in significant value generation, growth and market leadership. After leaving Thermo Fisher Scientific at the end of 2014, Markus dedicated his time to expand his experience into the entrepreneurship and earlystage investment industry. As Founding Partner of MGMS Consultancy, he supported the development of international scale-up programs for science and technology-based early-stage start-ups. Markus is a member of Chile Global Angels, the most active Angel investment network in Chile, and served on its board from 2016 to 2020.   Based on the results and feedback received from these initiatives, Markus decided to found The Ganesha Lab in 2017. Since then he has been leading the selection of and investment into 25+ pre-seed and seed stage biotech companies originating from 6 countries in LatAm, 7 of which he launched from LatAm to the US. Given the traction of the portfolio companies and the brand recognition of The Ganesha Lab, Markus decided to scale by launching The Ganesha Fund, a venture capital fund that together with The Ganesha Lab, can expand significantly the capacities and expected returns to current and new investors.